文献速递牙体牙髓病

局麻药溶液对不可逆性牙髓炎下牙槽神经阻滞成功率疗效的系统综述与网状Meta分析

Efficacy of local anaesthetic solutions on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a systematic review and network meta-analysis of randomized clinical trials.
PubMed 文献 · Int Endod J · 2019-02-12

结果显示仅甲哌卡因较利多卡因显著提高阻滞成功率(RR 1.42,95%CI 1.04-1.95),SUCRA排名甲哌卡因居首(0.81),证据质量极低至中等。

要点

  • 甲哌卡因较利多卡因显著提高不可逆性牙髓炎下牙槽神经阻滞成功率(RR 1.42)。
  • 甲哌卡因SUCRA排名第一(0.81),其次为丙胺卡因、阿替卡因、布比卡因、利多卡因。
  • 甲哌卡因与其他局麻药成功率差异无统计学意义,总体证据质量极低至中等。

核心结论

  • 基于纳入的随机临床试验证据,含肾上腺素的甲哌卡因用于不可逆性牙髓炎下牙槽神经阻滞时提供有效牙髓麻醉的概率最高。
  • 需进一步高质量临床试验支持该综述结论。

研究设计与样本

  • 纳入比较至少两种局麻药(利多卡因、阿替卡因、布比卡因、丙胺卡因或甲哌卡因)用于不可逆性牙髓炎下牙槽神经阻滞的随机临床试验。
  • 共纳入11项研究,样本量n=750。
  • 采用修订版Cochrane随机试验偏倚风险工具评估质量,行配对Meta分析、随机效应模型网状Meta分析和SUCRA排序,并用GRADE评估证据质量。

主要发现

  • 网状Meta分析显示仅甲哌卡因较利多卡因显著提高下牙槽神经阻滞成功率(RR 1.42,95%CI 1.04-1.95)。
  • 甲哌卡因与阿替卡因及布比卡因的下牙槽神经阻滞成功率差异无统计学意义。
  • SUCRA排序:甲哌卡因0.81第一,丙胺卡因0.62第二,阿替卡因0.54第三,布比卡因0.41第四,利多卡因0.13第五。
  • 总体证据质量极低至中等。

关键数值与推荐

  • 甲哌卡因对比利多卡因的下牙槽神经阻滞成功率RR为1.42(95%CI 1.04-1.95)。
  • SUCRA值:甲哌卡因0.81、丙胺卡因0.62、阿替卡因0.54、布比卡因0.41、利多卡因0.13。
  • 纳入研究共11项,样本量n=750。

临床怎么用

  • 对不可逆性牙髓炎下颌牙行下牙槽神经阻滞时,可优先考虑含肾上腺素的甲哌卡因以提高麻醉成功概率。
  • 选择局麻药时应结合SUCRA排序及证据质量极低至中等的局限进行个体化决策。

局限性

  • 总体证据质量极低至中等。
  • 甲哌卡因与其他局麻药的成功率差异无统计学意义。
  • 需进一步高质量临床试验支持结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The management of pain during root canal treatment is important. The aim of this systematic review and network meta-analysis was to identify the anaesthetic solution that would provide the best pulpal anaesthesia for inferior alveolar nerve blocks (IANB) treating mandibular teeth with irreversible pulpitis. Two electronic databases (PubMed and Scopus) were searched to identify studies up to October 2018. Randomized clinical trials comparing at least two anaesthetic solutions (lidocaine (lignocaine), articaine, bupivacaine, prilocaine or mepivacaine) used for IANB for treatment of irreversible pulpitis were included. The revised Cochrane risk of bias tool for randomized trials was used to assess the quality of the included studies. Pairwise meta-analysis, network meta-analysis using a random-effects model, and SUCRA ranking were performed. The network meta-analysis estimated the probability of each treatment performing best. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluations approach. In total, 11 studies (n = 750) were included in the meta-analysis. The network meta-analysis revealed that only mepivacaine significantly increased the success rate of IANB compared to lidocaine (RR, 1.42 [95% CI 1.04-1.95]). However, no significant differences in the success rate of IANB were observed between mepivacaine and other anaesthetic agents (articaine and bupivacaine). Of all anaesthetic agents, mepivacaine (SUCRA = 0.81) ranked first in increasing the success rate of IANB, followed by prilocaine (SUCRA = 0.62), articaine (SUCRA = 0.54), bupivacaine (SUCRA = 0.41) and lidocaine (SUCRA = 0.13). The overall quality of evidence was very low to moderate. In conclusion, based on the evidence from the randomized clinical trials included in this review, mepivacaine with epinephrine demonstrated the highest probability of providing effective pulpal anaesthesia using IANB for teeth with irreversible pulpitis compared to prilocaine, articaine, bupivacaine and lidocaine. Further, high-quality clinical trials are needed to support the conclusion of this review.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Nagendrababu V, Pulikkotil SJ, Suresh A, et al. Efficacy of local anaesthetic solutions on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a systematic review and network meta-analysis of randomized clinical trials. Int Endod J. 2019. PMID: 30638269. doi:10.1111/iej.13072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。